Ingo Bauerfeind

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm et al. · The Lancet Oncology · 2013 · 1.5K citations

Medicine, Oncology, Surgery +17

Quantitative Association Between HER-2/neu and Steroid Hormone Receptors in Hormone Receptor-Positive Primary Breast Cancer

Gottfried E. Konecny, Giovanni M. Pauletti, Mark D. Pegram et al. · JNCI Journal of the National Cancer Institute · 2003 · 590 citations · Full text

Medicine, Molecular Biology, Oncology +13

Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study

Michael Untch, Mahdi Rezai, Sibylle Loibl et al. · Journal of Clinical Oncology · 2010 · 557 citations · Full text

Medicine, Oncology, Pharmacology +17

Cognitive function during neoadjuvant chemotherapy for breast cancer

Kerstin Hermelink, Michael Untch, Michael P. Lux et al. · Cancer · 2007 · 358 citations · Full text

Medicine, Oncology, Psychology +14

Association between HER-2/<b> <i>neu</i> </b> and Vascular Endothelial Growth Factor Expression Predicts Clinical Outcome in Primary Breast Cancer Patients

Gottfried E. Konecny, Y. Gloria Meng, Michael Untch et al. · Clinical Cancer Research · 2004 · 315 citations · Full text

Medicine, Cancer Biology, Oncology +14